Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2020 Standalone Results
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2020 To 31/12/2020
Net Profit : 43,990,650
F/S Standalone Period : From 01/01/2019 To 31/12/2019
Net Comparative Profit : 110,265,836
Audit Status : Audited
Source : Glaxo Smith Kline
The BOD's Report (1,936 KB)
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2020 To 31/12/2020
Net Profit : 43,990,650
F/S Standalone Period : From 01/01/2019 To 31/12/2019
Net Comparative Profit : 110,265,836
Audit Status : Audited
Source : Glaxo Smith Kline
The BOD's Report (1,936 KB)
Comments